Persistent low-level viremia in persons living with HIV undertreatment: an unresolved status
C Crespo-Bermejo, ER de Arellano, V Lara-Aguilar… - Virulence, 2021 - Taylor & Francis
Antiretroviral therapy (ART) allows suppressed viremia to reach less than 50 copies/mL in
most treated persons living with HIV (PLWH). However, the existence of PLWH that show
events of persistent low-level viremia (pLLV) between 50 and 1000 copies/mL and with
different virological consequences have been observed. PLLV has been associated with
higher virological failure (VF), viral genotype resistance, adherence difficulties and AIDS
events. Moreover, some reports show that pLLV status can lead to residual immune …
most treated persons living with HIV (PLWH). However, the existence of PLWH that show
events of persistent low-level viremia (pLLV) between 50 and 1000 copies/mL and with
different virological consequences have been observed. PLLV has been associated with
higher virological failure (VF), viral genotype resistance, adherence difficulties and AIDS
events. Moreover, some reports show that pLLV status can lead to residual immune …
以上显示的是最相近的搜索结果。 查看全部搜索结果